Research

Cellular

The study failed to observe a statistically significant difference in the primary efficacy measure of ≥20 mg/dl difference in the 2-h OGTT at 3 months.

The lack of significant difference suggests that sitagliptin may not be effective in improving glucose tolerance in this population.

StrongRefutesmedium confidence
First, the study failed to observe a difference in the primary efficacy measure of ≥20 mg/dl difference in the 2-h OGTT at 3 mo.
Justin Oveyssi et al. · Transplantation · 2022

Why this rating

The claim is based on a randomized controlled trial.

Source

Prevention of Posttransplant Diabetes: A Complex Problem Without a Simple Solution

Justin Oveyssi et al. · Transplantation · 2022

DOI 10.1097/tp.0000000000004374

rct · n=61
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →